[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2012, 38(2) 107-109 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�Ƽ�������
���������������
̷����
������
����
PubMed
Article by Tan,C.H
Article by Luo,X.Y
Article by Yu,h

�Ƽ��ؿ�Ƥ�����ϻ������ü�����ӻ���

̷����,������,����

����ҽ�ƴ�ѧ������ͯҽԺƤ����

ժҪ��

���ϻ��IJ�����Ҫ�����������������߷���ʹƤ��ϸ���������������ϸ������������壬��������ϸ�����źż�����Ӧ������ת¼���Ӽ���ס�������-?��B�����յ���Ƥ����Ҫ���ʳɷֵĽ��⼰��֢�ķ������Ƽ�����ͨ������ת����������β���źŴ�������Ƥ����ԭ��������ˮ�������ȣ����ո���Ƥ���ϻ���ۼ��书��״̬���Ӳ����Ϸ��ι��ϻ����о����֣���ͬ����֯ϸ�������ﲻͬ�ĴƼ������壬Ƥ��ϸ����Ҫ���Ƽ�������-β����������ʱ���Ƽ�������-β����Ƽ�������-α�������ӹ����Ȳ�����Ӧ����ˣ�����������ѡ���ԴƼ������弤�������ι��ϻ�������Զ�����塣

�ؼ����� �Ƽ�������  

Anti?۲photoaging effects of estrogen and their molecular mechanisms

Abstract:

Photoaging is the superposition of chronic solar ultraviolet ��UV�� irradiation-induced damage and accounts for most age-associated changes in skin appearance. The molecular mechanisms of photoaging are triggered by reactive oxygen species ��ROS�� produced by skin cells after UV irradiation, which subsequently activate cell surface receptors, initiate intracellular signalling cascades, stimulate transcription factor activator proteins and nuclear factor-kappa B, and finally induce the degradation of skin extracellular matrix ��ECM�� and initiation of inflammation. Estrogen induces collagen synthesis, increases skin water content and improves the appearance and functions of photoaged skin by interfering with the transforming growth factor ��TGF-β/Smad signaling pathway, and finally prevents photoaging etiologically. Different tissues express different estrogen receptors ��ER��, and skin mainly expresses ER-β. When binding with the ligand, ER-β does not carry the breast and uterine proliferation liabilities of ER-α��therefore, to develop and utilize selective estrogen receptor activators may be of great value to the prevention and control of photoaging.

Keywords: Estrogen receptor  
�ո����� 2011-07-05 �޻����� 2011-08-14 ����淢������ 2012-02-29 
DOI:
������Ŀ:

2011���л�ҽѧ��——ŷ���� �й��˽���Ƥ���о���Ŀ

ͨѶ����: ����
���߼��:

�ο����ף�
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־